Newsbenzinga
Braveheart Bio Announces Late-breaking Presentation Of 52-Week Extension Data For BHB-1893 In Obstructive HCM At The American Heart Association Scientific Sessions, November 6-9; Will Also Host Webinar
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…